Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Severe and early hair loss may indicate a higher risk of heart disease.

Finasteride improves heart function in obese and aging male rats by reducing oxidative stress and p53 protein levels.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

The document concludes that individuals with a rare genetic disorder linked to the AEBP1 gene may experience a unique type of hair loss and should be monitored for heart issues.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Men with baldness, ear creases, and hairy ears have a higher risk of heart disease.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

More research is needed to understand how testosterone is maintained in adult males.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Early hair loss may indicate risk of insulin resistance.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.